Company Overview - Ventripoint Diagnostics Ltd. has developed software that transforms standard heart ultrasound machines into diagnostic tools that compete with expensive MRI scanners, significantly reducing costs and appointment complexities [4]. Business Model Shift - Following FDA approval, Ventripoint is transitioning from a traditional equipment sales model to a subscription-based service, facilitating easier adoption of their technology by healthcare providers [4]. Cost Comparison - Heart scans using Ventripoint's technology are priced at 5.5 times less than traditional MRI scans in the U.S., and the equipment costs are under 10% of conventional MRI systems [4]. Revenue Expectations - The company anticipates generating real revenue before the end of the year as it moves from product development to actual sales [4].